JCI
GCVRZ

Jet Capital Investors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Jet Capital Investors’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,832,053
Closed -$2.44M – 45
2019
Q4 		$2.44M Buy
2,832,053
+949,161
+50% +$729K 0.46% 29
2019
Q3 		$1.05M Buy
1,882,892
+1,854,369
+6,501% +$997K 0.22% 26
2019
Q2 		$15K Buy
+28,523
New +$14.2K ﹤0.01% 24

Jet Capital Investors's GCVRZ Position: Q1 2020 in Review

Jet Capital Investors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 2,832,053 shares — an estimated $2.44M sold.

Jet Capital Investors first reported a position in GCVRZ in Q2 2019 and held it in 3 quarters. The position peaked at $2.44M in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Jet Capital Investors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Jet Capital Investors sold 2,832,053 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $2.44M.
  • Jet Capital Investors first reported a position in Sanofi Contingent Value Rights in Q2 2019 and held it in 3 quarters.
  • Jet Capital Investors's Sanofi Contingent Value Rights position peaked at $2.44M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Jet Capital Investors's 13F filing for Q1 2020, filed 15 May 2020.